glp-1 sglt2 combination Updated evidence on cardiovascular and renal effects of receptor agonists and therapy with inhibitors and finerenone: a narrative review and perspectives | Cardiovascular Diabetology Early combination therapy with SGLT2i

R.MohammedI.BsheshK.MareiI.YeK.DingH.et al (2022)

Over the last few years, the use of glucagon-like peptide-1 receptor agonists (GLP-1 agonists) for managing type 2 diabetes has dramatically increased

Schoeneberg et al

All these bacteria have been associated also with other metabolic diseases and risk factors, such as obesity and inflammatory cytokines secretions [54]

Blood Sugar Control For people with type 2 diabetes, both oral and injectable GLP-1 medications can significantly improve blood sugar levels and lower A1C, which measures average blood glucose over the previous two to three months

Weight Loss Are you ready to start your weight loss journey